Who Buys Celecoxib from India — 781 Importers Behind a $133.6M Market
India's celecoxib import market is served by 781 active buyers who collectively imported $133.6M across 4,880 shipments. LIFESCIENCE LOGISTICS (UNITED STATES) leads with a 18.5% market share, followed by MACLEODS PHARMA USA ,INC and NELPA LIFESCIENCES INC. The top 5 buyers together control 44.0% of total import value, reflecting a moderately competitive buyer landscape.
Top Celecoxib Importers — Ranked by Import Value
LIFESCIENCE LOGISTICS (UNITED STATES) is the leading celecoxib importer from India, holding a 18.5% share of the $133.6M market across 4,880 shipments from 781 buyers. The top 5 buyers — LIFESCIENCE LOGISTICS (UNITED STATES), MACLEODS PHARMA USA ,INC (UNITED STATES), NELPA LIFESCIENCES INC (PHILIPPINES), CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES), J. KNIPPER & COMPANY (UNITED STATES) — collectively control 44.0% of total import value.
Top Celecoxib Buyers & Importers
Ranked by import value · 781 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | LIFESCIENCE LOGISTICSUNITED STATES CELECOXIB CAPSULES 100MG [PACK OF 500 CAPSULES]PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, SAPHLECOX 200PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, SAPHLECOX-400 | $24.7M | 5 | 18.5% |
| 2 | MACLEODS PHARMA USA ,INCUNITED STATES CELECOXIB CAPSULES 100MG [PACK OF 500 CAPSULES]CELECOXIB CAPSULE 200 MG_100S_AP_US | $13.7M | 5 | 10.2% |
| 3 | NELPA LIFESCIENCES INCPHILIPPINES PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, SAPHLECOX 200PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, SAPHLECOX-400 | $10.4M | 5 | 7.8% |
| 4 | CIPLA USA INC UPS SUPPLY CHAIN SOLUUNITED STATES CELECOXIB CAPSULES 100MG [PACK OF 500 CAPSULES]CELECOXIB CAPSULE 200 MG_100S_AP_US | $5.7M | 5 | 4.3% |
| 5 | J. KNIPPER & COMPANYUNITED STATES CELECOXIB CAPSULES 100MG [PACK OF 500 CAPSULES]CELECOXIB CAPSULE 200 MG_100S_AP_USAPO-CELECOXIB CAP 200MG 100 BTL 53810/77 | $4.3M | 5 | 3.2% |
| 6 | NORTHSTAR DISTRIBUTION CENTER 8912UNITED STATES CELECOXIB CAPSULES 100MG [PACK OF 500 CAPSULES]CELECOXIB CAPSULE 200 MG_100S_AP_US | $3.5M | 5 | 2.6% |
| 7 | J KNIPPER COMPANYUNITED STATES CELECOXIB CAPSULES 100MG [PACK OF 500 CAPSULES]CELECOXIB CAPSULE 200 MG_100S_AP_USCELEBIB 200 1 | $2.6M | 5 | 1.9% |
| 8 | THE MAURITIUS PHARMACY (SEEGOBIN) LMAURITIUS CELECOXIB CAPSULES 100MG [PACK OF 500 CAPSULES]PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, SAPHLECOX 200PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, SAPHLECOX-400 | $2.1M | 5 | 1.5% |
| 9 | MERCKLE GMBHGERMANY 240252, CELECOXIB 200MG HK, BATCH 122033240252, CELECOXIB 200MG HK, BATCH 122021240252, CELECOXIB 200MG HK, BATCH 122019 | $1.7M | 5 | 1.3% |
| 10 | CONTROLLED MEDICATIONS LTDHONG KONG | $1.7M | 5 | 1.3% |
| 11 | E.P.DISFRANCE CELEBID 200 )CELEBID 200 (CELEBID 200 | $1.6M | 5 | 1.2% |
| 12 | APOTEX INC,CANADA APO-CELECOXIB CAP 200MG 100 BTL 53810/77MINT CELECOXIB CAPS 200MG 100'S CANADAMINT CELECOXIB CAPS 100MG 100'S CANADA | $1.5M | 5 | 1.1% |
| 13 | J. KNIPPER & COMPANY,UNITED STATES CELECOXIB CAPSULES 100MG [PACK OF 500 CAPSULES]CELECOXIB CAPSULE 200 MG_100S_AP_USAPO-CELECOXIB CAP 200MG 100 BTL 53810/77 | $1.5M | 5 | 1.1% |
| 14 | J.KNIPPER & COMPANYUNITED STATES CELECOXIB CAPSULES 100MG [PACK OF 500 CAPSULES]CELECOXIB CAPSULE 200 MG_100S_AP_US | $1.5M | 5 | 1.1% |
| 15 | SUNSHINE HEALTHCARE LANKA LIMITEDSRI LANKA CELECOXIB CAPSULES 100MG CELECOXIB 10X10ZYCEL 200MG CAPSULESCELECOXIB10X10ZYCEL 200MG CAPSULES | $1.4M | 5 | 1.0% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Celecoxib — and from which countries?
Flow of Celecoxib exports from India: each country's share and the named importers behind the numbers
Celecoxib — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $66.7M through 794 shipments. This represents a market share of 49.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• LIFESCIENCE LOGISTICS - $24.7M (37.0% of country's total business)
• MACLEODS PHARMA USA ,INC - $13.7M (20.5% of country's total business)
• CIPLA USA INC UPS SUPPLY CHAIN SOLU - $5.7M (8.6% of country's total business)
• J. KNIPPER & COMPANY - $4.3M (6.4% of country's total business)
• NORTHSTAR DISTRIBUTION CENTER 8912 - $3.5M (5.2% of country's total business)
• Rest of United States's importers - $14.9M (22.3% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $84.0K, indicating premium pricing strategy compared to the market average of $27.4K.
United States is a key market for Celecoxib imports, representing 49.9% of total trade value.
2Philippines
Philippines emerges as the second largest importing country, achieving a total trade value of $13.7M through 68 shipments. This represents a market share of 10.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Philippines has a diverse importer base, with their top importers including:
• NELPA LIFESCIENCES INC - $10.4M (76.2% of country's total business)
Key Insight: Philippines demonstrates strong market positioning with an average shipment value of $201.1K, indicating premium pricing strategy compared to the market average of $27.4K.
Philippines is a key market for Celecoxib imports, representing 10.2% of total trade value.
3Canada
Canada emerges as the third largest importing country, achieving a total trade value of $7.1M through 110 shipments. This represents a market share of 5.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• APOTEX INC, - $1.5M (21.6% of country's total business)
• MARCAN PHARMACEUTICALS INC. - $1.0M (14.6% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $64.2K, indicating premium pricing strategy compared to the market average of $27.4K.
Canada is a key market for Celecoxib imports, representing 5.3% of total trade value.
4France
France emerges as the fourth largest importing country, achieving a total trade value of $3.4M through 36 shipments. This represents a market share of 2.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: France has a diverse importer base, with their top importers including:
• E.P.DIS - $1.6M (46.4% of country's total business)
Key Insight: France demonstrates strong market positioning with an average shipment value of $95.2K, indicating premium pricing strategy compared to the market average of $27.4K.
France is a key market for Celecoxib imports, representing 2.6% of total trade value.
5Germany
Germany emerges as the fifth largest importing country, achieving a total trade value of $3.1M through 41 shipments. This represents a market share of 2.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Germany has a diverse importer base, with their top importers including:
• MERCKLE GMBH - $1.7M (56.5% of country's total business)
Key Insight: Germany demonstrates strong market positioning with an average shipment value of $75.3K, indicating premium pricing strategy compared to the market average of $27.4K.
Germany is a key market for Celecoxib imports, representing 2.3% of total trade value.
Buyer Segment Analysis
TransData Nexus Celecoxib buyer market intelligence
1Buyer Segment Analysis
The 781 buyers of Celecoxib from India can be categorized into several segments:
1. Distributors: Entities that purchase large quantities to supply to various healthcare providers.
2. Contract Manufacturers: Companies that produce pharmaceuticals for other brands.
3. Retail Chains: Pharmacy chains that procure medicines for direct consumer sales.
4. Government Procurement: Public sector entities purchasing for national healthcare programs.
5. Re-exporters: Companies importing for the purpose of exporting to other markets.
Each segment's purchasing patterns are influenced by their operational needs, market demand, and regulatory requirements.
Country-Specific Import Regulations
TransData Nexus Celecoxib buyer market intelligence
1Country-Specific Import Regulations
- 1Regulatory Authority: Food and Drug Administration (FDA).
- 2Import Registration Process: Requires FDA approval through the New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) process.
- 3Estimated Timeline: 6-10 months for ANDA approval.
- 4Import Tariff/Duty: Generally 0% for pharmaceuticals under HS Code 30049069.
United States:
- 1Regulatory Authority: Food and Drug Administration Philippines.
- 2Import Registration Process: Submission of a Certificate of Product Registration (CPR) application.
- 3Estimated Timeline: 4-6 months.
- 4Import Tariff/Duty: 5% under HS Code 30049069.
Philippines:
- 1Regulatory Authority: Health Canada.
- 2Import Registration Process: Requires a Drug Identification Number (DIN) through the New Drug Submission (NDS) process.
- 3Estimated Timeline: 6-12 months.
- 4Import Tariff/Duty: 0% under HS Code 30049069.
Canada:
- 1Regulatory Authority: Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM).
- 2Import Registration Process: Marketing Authorization Application (MAA) submission.
- 3Estimated Timeline: 7-10 months.
- 4Import Tariff/Duty: 0% under HS Code 30049069.
France:
- 1Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).
- 2Import Registration Process: Submission of a Marketing Authorization Application (MAA).
- 3Estimated Timeline: 7-10 months.
- 4Import Tariff/Duty: 0% under HS Code 30049069.
Germany:
Demand Drivers & Market Opportunity
TransData Nexus Celecoxib buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Celecoxib is primarily driven by the prevalence of chronic inflammatory conditions such as osteoarthritis and rheumatoid arthritis. According to the World Health Organization (WHO), these conditions are significant contributors to disability worldwide. The inclusion of Celecoxib in the WHO Model List of Essential Medicines underscores its importance in managing these diseases. (who.int)
Government healthcare programs and the expansion of universal health coverage in many countries have increased access to essential medicines, including Celecoxib. The WHO's emphasis on essential medicines aims to ensure availability and affordability, thereby boosting demand. Tender-based purchasing by national health systems further facilitates large-scale procurement, enhancing market opportunities for suppliers. (who.int)
Common Questions — Celecoxib Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest celecoxib buyer importing from India?
Based on import volume and value, LIFESCIENCE LOGISTICS (UNITED STATES) leads with $24.7M in imports and a 18.5% market share — the highest of any single celecoxib importer. MACLEODS PHARMA USA ,INC (UNITED STATES) and NELPA LIFESCIENCES INC (PHILIPPINES) are the next largest buyers.
QHow many companies buy celecoxib from India?
There are 781 active celecoxib buyers importing from India, with a combined market of $133.6M across 4,880 shipments to 112 countries. The top 5 buyers hold 44.0% of total import value, while the remaining 776 buyers handle the other 56.0%.
QWhich countries import the most celecoxib from India?
The top importing countries for celecoxib from India are United States (49.9%), Philippines (10.2%), Canada (5.3%), France (2.6%), Germany (2.3%). These markets represent the largest demand centres for Indian pharmaceutical exports of celecoxib, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for celecoxib from India?
The average import transaction value for celecoxib from India is $27.4K, with an average unit price of $4.39 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Celecoxib buyer market intelligence
1Buyer Segment Analysis
The 781 buyers of Celecoxib from India can be categorized into several segments:
1. Distributors: Entities that purchase large quantities to supply to various healthcare providers.
2. Contract Manufacturers: Companies that produce pharmaceuticals for other brands.
3. Retail Chains: Pharmacy chains that procure medicines for direct consumer sales.
4. Government Procurement: Public sector entities purchasing for national healthcare programs.
5. Re-exporters: Companies importing for the purpose of exporting to other markets.
Each segment's purchasing patterns are influenced by their operational needs, market demand, and regulatory requirements.
Country-Specific Import Regulations
TransData Nexus Celecoxib buyer market intelligence
1Country-Specific Import Regulations
- 1Regulatory Authority: Food and Drug Administration (FDA).
- 2Import Registration Process: Requires FDA approval through the New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) process.
- 3Estimated Timeline: 6-10 months for ANDA approval.
- 4Import Tariff/Duty: Generally 0% for pharmaceuticals under HS Code 30049069.
United States:
- 1Regulatory Authority: Food and Drug Administration Philippines.
- 2Import Registration Process: Submission of a Certificate of Product Registration (CPR) application.
- 3Estimated Timeline: 4-6 months.
- 4Import Tariff/Duty: 5% under HS Code 30049069.
Philippines:
- 1Regulatory Authority: Health Canada.
- 2Import Registration Process: Requires a Drug Identification Number (DIN) through the New Drug Submission (NDS) process.
- 3Estimated Timeline: 6-12 months.
- 4Import Tariff/Duty: 0% under HS Code 30049069.
Canada:
- 1Regulatory Authority: Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM).
- 2Import Registration Process: Marketing Authorization Application (MAA) submission.
- 3Estimated Timeline: 7-10 months.
- 4Import Tariff/Duty: 0% under HS Code 30049069.
France:
- 1Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).
- 2Import Registration Process: Submission of a Marketing Authorization Application (MAA).
- 3Estimated Timeline: 7-10 months.
- 4Import Tariff/Duty: 0% under HS Code 30049069.
Germany:
Demand Drivers & Market Opportunity
TransData Nexus Celecoxib buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Celecoxib is primarily driven by the prevalence of chronic inflammatory conditions such as osteoarthritis and rheumatoid arthritis. According to the World Health Organization (WHO), these conditions are significant contributors to disability worldwide. The inclusion of Celecoxib in the WHO Model List of Essential Medicines underscores its importance in managing these diseases. (who.int)
Government healthcare programs and the expansion of universal health coverage in many countries have increased access to essential medicines, including Celecoxib. The WHO's emphasis on essential medicines aims to ensure availability and affordability, thereby boosting demand. Tender-based purchasing by national health systems further facilitates large-scale procurement, enhancing market opportunities for suppliers. (who.int)
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 781 global importers of Celecoxib identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 4,880 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 112 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,880 Verified Shipments
781 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists